| Website | intersouth.com |
| @intersouth | |
| Phone | 919.493.6640 |
| info@intersouth.com | |
| Employees | |
| Founded | 1984 |
Intersouth Partners is one of the most active and experienced venture funds in the Southeast, having invested in more than 90 private companies over the last two decades. Founded in 1985, Intersouth manages $780 million in seven venture capital limited partnerships, making it the largest venture capital fund in North Carolina and one of the largest in the Southeast.
| Company | Date | Round | Size | Participants |
| Locaid | 6/13 | Series D | $4.05M | 3 |
| Advanced Animal Diagnostics | 4/13 | Series B | $6M | 2 |
| PeopleMatter | 3/13 | Venture Round | $19M | 6 |
| Applied Genetics Technologies Corporation | 11/12 | Series B | $37.5M | 6 |
| Zenoss | 10/12 | Series C | $25M | 4 |
| Vascular Pharmaceuticals | 9/12 | Series A | $16M | 2 |
| Argos Therapeutics | 4/12 | Series D | $25M | 5 |
| Adaptivity | 3/12 | Series B | $3M | 3 |
| 480 Biomedical | 2/12 | Series A | $15M | 3 |
| Semprius | 1/12 | Venture Round | $7.5M | 3 |
| CSA Medical | 12/11 | Series B | $20.5M | 4 |
| simplifyMD | 11/11 | Series A | $4.5M | 1 |
| Arsenal Vascular | 10/11 | Venture Round | $3M | 3 |
| Adaptivity | 9/11 | Venture Round | $6M | 3 |
| 6fusion | 8/11 | Series B | $7M | 2 |
| Semprius | 6/11 | Series C | $20M | 6 |
| PeopleMatter | 5/11 | Series B | $7.2M | 4 |
| Advanced Animal Diagnostics | 3/11 | Series B | $11M | 2 |
| Locaid | 2/11 | Series C | $13M | 2 |
| CallMiner | 10/10 | Venture Round | $7M | 3 |
| Adaptivity | 10/10 | Series A | $7.2M | 2 |
| CallMiner | 9/10 | Series C | $4M | 3 |
| 6fusion | 8/10 | Series A | $3M | 1 |
| Arsenal Vascular | 5/10 | Venture Round | $10M | 3 |
| Overture Networks | 4/10 | Venture Round | $17.2M | 7 |
| Arsenal Vascular | 3/10 | Debt | $1M | 3 |
| PeopleMatter | 2/10 | Venture Round | $7.2M | 2 |
| ABT Molecular Imaging | 1/10 | Series A | $9M | 1 |
| TransEnterix | 1/10 | Series B | $55M | 6 |
| MicroCHIPS | 1/10 | Venture Round | $16.5M | 9 |
| Calibra Medical | 11/09 | Venture Round | $1.4M | 5 |
| Zenph Sound Innovations | 11/09 | Series A | $10.7M | 2 |
| Alimera Sciences | 10/09 | Series C | $5M | 5 |
| Viamet Pharmaceuticals | 7/09 | Series B | $18M | 6 |
| Semprius | 6/09 | Series B | $6.4M | 5 |
| Applied Genetics Technologies Corporation | 6/09 | Series C | $11.8M | 3 |
| Cempra | 6/09 | Series C | $46M | 6 |
| Proteon Therapeutics | 5/09 | Series B | $50M | 8 |
| Bright View Technologies | 4/09 | Series C | $4M | 4 |
| Biolex Therapeutics | 10/08 | Series D | $60M | 12 |
| Athenix | 7/08 | Series D | $10M | 3 |
| siXis | 6/08 | Series A | $5M | 2 |
| Aldagen | 4/08 | Series D | $18.4M | 4 |
| Mixx | 2/08 | Series B | $2M | 1 |
| Zenoss | 1/08 | Series B | $11M | 4 |
| Proteon Therapeutics | 9/07 | Series A | $12M | 4 |
| Mixx | 9/07 | Series A | $1.5M | 1 |
| Aldagen | 9/07 | Series C | $9M | 4 |
| Semprius | 7/07 | Series A | $4.1M | 3 |
| Argolyn Bioscience | 6/07 | Series A | $15.8M | 3 |
| Viamet Pharmaceuticals | 6/07 | Series A | $4M | 2 |
| Biolex Therapeutics | 5/07 | Series C | $30M | 9 |
| FlatBurger | 5/07 | Series A | $5M | 2 |
| Defywire | 3/07 | Venture Round | $7M | 3 |
| 6th Sense Analytics | 1/07 | Series A | $5M | 2 |
| Ziptronix | 1/07 | Series D | $2.8M | 5 |
| Jacket Micro Devices | 10/06 | Venture Round | $12M | 4 |
| Zenoss | 8/06 | Series A | $4.8M | 4 |
| COVEGA | 8/06 | Venture Round | $10M | 4 |
| CallMiner | 7/06 | Series B | $10M | 4 |
| Nitronex | 6/06 | Venture Round | $21.8M | 6 |
| Overture Networks | 6/06 | Series C | $7.5M | 6 |
| KAI Pharmaceuticals | 5/06 | Series B | $35M | 7 |
| FlatBurger | 3/06 | Seed | $1.75M | 2 |
| Athenix | 1/06 | Series C | $13M | 6 |
| HexaTech | 11/05 | Series A | $8.9M | 4 |
| Alimera Sciences | 11/05 | Series B | $31.8M | 5 |
| Locaid | 11/05 | Series A | $5M | 2 |
| 6th Sense Analytics | 11/05 | Venture Round | $1.7M | 1 |
| TapRoot Systems | 9/05 | Series B | $6.5M | 3 |
| Biolex Therapeutics | 9/05 | Series B | $36M | 6 |
| Ziptronix | 8/05 | Series C | $7.2M | 6 |
| Defywire | 4/05 | Series B | $3.6M | 3 |
| Digital Safety Technologies | 4/05 | Venture Round | $41.1M | 5 |
| Invistics | 1/05 | Series B | $5M | 3 |
| Athenix | 1/04 | Series B | $12.5M | 5 |
| Applied Genetics Technologies Corporation | 11/03 | Series B | $27M | 4 |
| Athenix | 9/01 | Series A | $8M | 3 |
| Sentillion | 9/01 | Series C | $18M | 7 |
| Sentillion | 4/00 | Series B | $8.75M | 5 |
| Sentillion | 3/99 | Series A | $2.7M | 3 |
